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Study design: A phantom experiment, two thermocouple experiments, three in vivo pig experiments, and a
simulated treatment on a healthy human volunteer were conducted to test the feasibility, safety, and efficacy of
magnetic resonance-guided focused ultrasound (MRgFUS) for treating facet joint pain.
Objective: The goal of the current study was to develop a novel method for accurate and safe noninvasive facet
joint ablation using MRgFUS.
Summary of background data: Facet joints are a common source of chronic back pain. Direct facet joint
interventions include medial branch nerve ablation and intra-articular injections, which are widely used, but limited
in the short and long term. MRgFUS is a breakthrough technology that enables accurate delivery of high-intensity
focused ultrasound energy to create a localized temperature rise for tissue ablation, using MR guidance for treatment
planning and real-time feedback.
Methods: We validated the feasibility, safety, and efficacy of MRgFUS for facet joint ablation using the ExAblate 2000®
System (InSightec Ltd., Tirat Carmel, Israel) and confirmed the system's ability to ablate the edge of the facet joint and
all terminal nerves innervating the joint. A phantom experiment, two thermocouple experiments, three in vivo pig
experiments, and a simulated treatment on a healthy human volunteer were conducted.
Results: The experiments showed that targeting the facet joint with energies of 150–450 J provides controlled and
accurate heating at the facet joint edge without penetration to the vertebral body, spinal canal, or root foramina.
Treating with reduced diameter of the acoustic beam is recommended since a narrower beam improves access to the
targeted areas.
Conclusions: MRgFUS can safely and effectively target and ablate the facet joint. These results are highly significant,
given that this is the first study to demonstrate the potential of MRgFUS to treat facet joint pain.
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Lumbar zygapophysial joint arthropathy is a challenging
condition affecting up to 15% of patients with chronic
low back pain. The onset of lumbar facet joint pain is
usually insidious with predisposing factors including
spondylolisthesis, degenerative disc pathology, and old* Correspondence: sagi.harnof@sheba.health.gov.il
†Equal contributors
1Department of Neurological Surgery, Sheba Medical Center, Ramat Gan
52621, Israel
Full list of author information is available at the end of the article
© 2014 Harnof et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orage [1]. Facet joint ablation to reduce low back pain is
a medically accepted and reimbursed procedure, which is
gaining more and more popularity recently. The evidence
for pain relief after radiofrequency (RF) neurotomy of the
cervical and lumbar medial branch nerves is moderate for
short- and long-term pain relief, and indeterminate for
thoracic facet neurotomy [2,3]. Noninvasive thermal abla-
tion using magnetic resonance-guided focused ultrasound
(MRgFUS) has been found to be clinically effective for the
palliation of pain caused by bone metastases [4-6] and is
currently being evaluated in a pivotal clinical study.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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invasive thermoablation of various benign and malignant
soft tissue and bone tumors. The ExAblate 2000® system
(InSightec Ltd., Tirat Carmel, Israel) delivers treatment
using focused ultrasound (FUS) in conjunction with
real-time magnetic resonance imaging (MRI) guidance to
selectively ablate targeted tissue by inducing localized
heating [7]. The uniqueness of MRgFUS is based on a
technology that facilitates real-time MRI monitoring and
control, thereby supplying a high-quality anatomical image
of the patient's internal organs and a real-time temperature
map for monitoring the thermal rise in the targeted region
[7-9]. Accordingly, this allows for treatment adjustments
based on ongoing monitoring of the therapeutic effect on
the tissue and also assures maximum efficiency and safety.
Such real-time feedback does not exist for other localized
treatment modalities. The current study evaluated the
feasibility, safety, and efficacy of MRgFUS for facet joint
pain palliation using a series of in vitro and animal studies,
as well as a simulated treatment on a healthy human volun-
teer. Specifically, this study aimed to build the foundation
of data required for initiating phase 1 clinical research.
The rationale behind performing several types of experi-
ments was to evaluate the potential of MRgFUS for facet
joint ablation using various tools, thereby compensating
for the advantages and disadvantages of each. The goal
of the phantom experiment was to measure the relative
thermal rise in the entire three-dimensional volume of
tissue surrounding the vertebra using MR thermometry.
The goal of the thermocouple experiments was to provide
a more accurate and absolute thermal reading focused on
the areas, which if damaged, could cause neurological
deficits. The goal of the animal experiments was to examine
real-time thermometry in a living organism as well as post-
treatment clinical imaging and histopathology evaluation of
treatment outcome. The goal of the simulated treatment on
a healthy human volunteer was to project our animal study
results on a human anatomical model.
Materials and methods
In order to evaluate the feasibility, safety, and efficacy
of MRgFUS for facet joint pain palliation, a phantom
experiment, two thermocouple experiments, three in vivo
pig experiments, and a simulated treatment on a healthy
human volunteer were conducted. All experiments were
conducted using the ExAblate 2000® System, with imaging
done by the system pelvic coil. The experiments took
place at Sheba Medical Center (Tel Hashomer, Israel).
The research team constituted collaboration between
Dr. Sagi Harnof and Dr. Zion Zibly (neurosurgeons),
Dr. Yael Inbar (radiologist), Dr. Israel Caspi and Dr. Shay
Tenenbaum (orthopedic spine surgeons), and Dr. Itay
Goor-Aryeh and Dr. Adrian Greenfeld (anesthesiolo-
gists and pain specialists). All animal experiments wereperformed under local animal ethics committee approvals.
The imaging session on a human volunteer was performed
with approval from the local human ethics committee
(Sheba Medical Center, Israel) and after the subject gave
his consent. Based on current results and accumulated
data from bone metastases ablation [4,5], we estimated
that sonications of 150–450 J with appropriate angling
would provide the desired therapeutic effect for accurate
ablation of the facet joint within a safe margin.
Magnetic resonance-guided focused ultrasound technology
MRgFUS treatment commences with a planning phase,
whereby the physician co-registers and analyzes the MR
and CT images, defines the targeted area for treatment,
and prescribes a detailed treatment plan. After the tar-
geted location is defined and confirmed, the parameters
are adjusted using the ExAblate software. The treatment
is based on multiple sonication spots that accumulate to
cover the targeted volume. In combination with real-time
guidance, the ExAblate system maneuvers the robotic arm
of the ultrasound probe to deliver the acoustic energy
to the targeted region. Since the facet joint is a major
contributor of pain in patients with lumbar zygapophysial
joint arthropathy, ablating the source of pain has the poten-
tial to produce lasting pain relief. Since this process also de-
stroys local nerve endings, potential pain palliation is very
rapid. During delivery of the FUS energy to each treatment
spot, thermal images provide real-time feedback of the
treatment location and measure thermal rise, allowing the
physician to adjust the treatment parameters for the desired
result. Finally, posttreatment contrast imaging is used to
confirm the treatment outcome, based on nonperfused
volume (NPV), which represents successful ablation.
Phantom experiment (MR thermometry)
In order to monitor thermal rise in nominal treatment
conditions as well as in a worst-case scenario, in the far
field of the acoustic beam and near sensitive areas neigh-
boring nontargeted nerves, a phantom experiment was
performed. A soft-tissue-mimicking phantom containing
two adjacent pig vertebrae was prepared (Figure 1). Two
bilateral facet joints were treated using extreme energies
(up to four times the expected scenario, Table 1). During
the treatment, online monitoring of temperatures was
performed using MR thermometry. For each sonication,
temperature rise was measured at the focal point and in the
far field adjacent to the intervertebral foramen (Figure 2).
Measurements from all sonications are summarized and
are presented in a single graph showing thermal rise vs.
deposited energy (Figure 3).
Phantom experiment (thermocouple measurements)
In order to confirm the results of MR thermometry, an
experiment using a fresh pig's spine embedded in gel
Figure 1 Axial proton density (PD) images of facet joint phantom used in the experiment. Red arrows show two facet joints on several slices.
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the far field was performed (Figure 4). Different sonication
parameters and treatment techniques were used in order
to assess thermal rise in several far field nerve roots during
nominal- and high-energy sonications.
In vivo animal experiments
MRgFUS procedures were performed on the facet joints
of three young pigs (4–6 months old). Six to eight facet
joints in each pig were treated with energies of 150, 300,
and 450 J. Thoracic and lumbar spine vertebrae were
treated from different orientations with appropriate ac-
cess. Following the MRgFUS procedure, the second and







Average temperature in the
vicinity of the intervertebral
foramen (°C)
1 300 61 38
2 300 65 38
3 300 73 38
4 300 84 37
5 300 62 38
6 300 59 39
7 300 66 37
8 300 65 38
9 300 71 39
10 600 83 38
11 600 67 37
12 900 72 39
13 900 75 42
14 1,200 78 43
15 1,200 64 41
Summary of the sonication parameters used in the phantom experiment,
including acoustic energy delivered, the temperature measured at the focal point
on the targeted facet joint, and the temperature measured in the nontargeted
intervertebral foramina, located in the far field of the acoustic beam.(Lahav, Israel) for veterinary care and follow-up. The
first pig remained at the Sheba Animal Laboratory and
was imaged and sacrificed after 1 day of follow-up. The
second pig went through the same procedure after 1
week of follow-up, and the third pig after 6 weeks.
Each facet joint was treated with 2–4 sonications for
maximal coverage. Focus was placed on the facet joint
surface, and each sonication orientation was adjusted to
avoid heating of the spinous process in the near field
and nerve roots and spinal canal heating in the far field
(Figure 5). In the treatment of the third pig, a transducer
apodization technique was used in half of the facet joints
that were treated, which allowed shutting off the outer
elements of the transducer (blue ring in Figure 6) and
sonicating with a narrower beam pass zone (radius = 80%).
Planned power was applied using only enabled elements.
A narrower beam allows better optimization of the
transducer orientation (against the sensitive locations in
the beam pass zone) since it minimizes the beam pass
zone intersection with the vertebral spinous process.
Immediately following the procedure, a set of high-
quality images, with and without contrast agent (i.v. gado-
linium, 1 ml/5 kg), were acquired to evaluate damage to
the targeted tissue (Figures 7 and 8). Upon completion of
the follow-up period (1 day, 1 week, and 6 weeks for each
of the three pigs, respectively), a dissection was performed
to examine the gross pathology of the treated regions and
nearby tissue in all three pigs. Specimens of lesions and
the nerve roots located anterior to the targeted facet joints
were sent to the pathology laboratory (Sheba Medical
Center) for histological examination.Histology
Histological examination using hematoxylin and eosin
stains was performed for all nerve roots located anterior
to the treatment area (a total of eight roots). In addition,
for each studied animal, hematoxylin and eosin stains
were performed for the entire relevant segment of the
spinal cord and dura along with two segments below
and above the lesion level.
Figure 2 Temperature measurements at the point of focus and in the far field, adjacent to the intervertebral foramen. As measured
during sonication #13 (900 J). Red (maximum) and green (average) temperature curves represent the point of focus; yellow temperature curve
represents the far field, adjacent to the intervertebral foramen.
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In order to verify safe accessibility of the acoustic beam, a
treatment simulation was performed on a human volunteer.
The main purpose of this simulation was to check the
accessibility of the acoustic beam to human facet joints
as well as to test on the human spine different orientation
techniques that were applied during pig experiments.
During this session, a healthy volunteer was positioned
supine, feet first, on a 4-cm gel pad on an ExAblate 2000®
table. Images were downloaded later to the demo mode
ExAblate 2000® workstation, and a plan of the treatment
simulation was generated. These images were taken as
part of an imaging session, which was performed in Sheba
Medical Center and under approval of the local IRB. An
example of a treatment plan for two facet joints is shown
in Figure 9.Figure 3 Thermal rise vs. deposited energy. The graph shows average t
acoustic beam, adjacent to the intervertebral foramen as function of deliveResults
Phantom experiment (MR thermometry)
The phantom experiment showed that targeting the
facet joints using the ExAblate 2000® system can produce
controlled heating in the facet joint. Spinal nerve roots
showed a temperature rise of 6°C in the extreme-case
scenario, represented by treatment with 1,200 J, which
is four to eight times more than the expected nominal
energy (the temperature rise is linearly correlated to
the energy). A summary of the measurement results is
displayed in Table 1. Although a nominal treatment of
the facet joint should be performed using a frequency
of f = 1.35 MHz in order to minimize the risk of acous-
tic energy penetration into the vertebra (the higher the
frequency, the higher the absorption at the bone surface),
in this experiment, several of the nominal and allemperature measured using MR thermometry in the far field of the
red energy.
Figure 4 Left view of the pig spine with thermocouples attached adjacent to the intervertebral foramen.
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frequency of f = 1 MHz, for which the penetration of ultra-
sound into the bone is higher. As recorded in Table 1,
there is a linear and consistent elevation of temperature
consistent with the increase of energy. The temperature
elevation at the focal point did not show this linear and
consistent elevation, which is believed to be due to the fact
that the focus on the bone surface creates high energy
density levels on the facet joint (the smaller the area and
the higher the energy levels are), and minor changes like
spot location or an angle can create a variety of results.
Phantom experiment (thermocouple measurements)
The results of the thermocouple experiment confirm the
ability to induce a controlled temperature rise at the
targeted facet joint and nearby tissue with minimal heat-
ing of the nontargeted area. In the extreme-case scenario,Figure 5 MR images showing planning of sonication with focal spot o
and sagittal planes to protect the spinal nerve roots (white areas on the image
and the spinal canal (marked by green dashed circle) from exposure to the acowhich included the worst possible orientation of the
acoustic beam, a temperature rise of 5.2°C was measured
in the far field at the nerve root location, which is still an
acceptable situation. These results correlate well with the
results of the MR thermometry phantom experiment.
The results showing specific measurements from the
nerve root foramina are summarized in Table 2. In one
sonication, using 300 J, the transducer orientation was
such that the foramen was at the center of the acoustic
beam in the far field. In this case, the temperature rise
reached 5.2°C. The measurements are displayed on the
graph in Figure 10.
In vivo animal experiments
Treating the facet joints with energies of 150, 300, and
450 J resulted in a controlled heating at the facet joint
edge with no penetration to the vertebral body, whichn the facet joint. Appropriate beam orientation is applied in the axial
, marked with red arrows), the spinous process (marked with yellow arrow),
ustic beam.
Figure 6 The ExAblate 2000® transducer and its division to
separate elements. Red represents a working element and blue
represents a disabled element. Apodization technique shapes the
acoustic beam by switching off certain transducer elements; in this
example, seven outer rings of transducer elements were switched
off to create a narrower acoustic beam.
Figure 7 Coronal T1-weighted contrast-enhanced MR image
showing the NPV at the facet joint edges of the treated pig.
More significant treatment effect can be seen on the left facet joints
that were treated with 300 J (marked by yellow arrows) vs. the right
facet joints that were treated with 150 J.
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images showed soft tissue edema and small nonenhanced
regions on the edges of the treated facet joints (Figure 11).
A higher treatment effect was observed on facet joints that
were treated with higher energies (Figure 11).
A neurological follow-up was performed following the
experiment, which included a series of tests for walking,
light running, abrupt standing up, and eating and drinking
habits. According to the veterinary evaluation at Lahav, the
last two pigs treated had a normal neurological evaluation
result and were eating and drinking normally. In the gross
pathology evaluation of the first two pigs (the third still in
follow-up), there was no evidence of thermal damage to the
spinal column or spinal nerve root.
Based on the final histological evaluation of all specimens,
there is no evidence of nerve damage or adverse changes
associated with the treatment. No histological changes
were seen on the nerve roots or spinal cord; specifically,
no ablative changes were seen. However, at the edge of
the targeted facet joint, we were able to identify ablative
changes as expected.
Treatment simulation on human spine
We demonstrated the ability to target the facet joint and
that the avoidance of critical structures by the ultrasound
beam is well within the system's capabilities. The main
results of this demo are shown in Figure 9, which shows
the system planning spots in green and that the targeted
facet joint is device accessible.Discussion
Facet joint pain is a common and challenging condition.
Current existing treatment options include RF ablation
and spinal calm stabilization with hardware. Both these
techniques are invasive yet effective with some drawback.
The evidence supporting pain relief and control following
RF ablation is diverse in the literature, with pain relief
success rate of 55%–85% at 1 year [1,2]. Systematic reviews
have established moderate and limited evidence for radio-
frequency neurotomy of thoracic medial branches [2,3].
Manchikanti et al. reviewed 13 studies and concluded that
the evidence for therapeutic benefit is limited for RF
neurotomy [10]. In addition, the efficacy of both short-
and long-term pain relief is moderate and limited [2].
Stabilization of the effected facet by means of hardware
and fusion carries limitation with pain relief and surgical
complications, and there is consensus on its value. Cohen
et al. reported that there is no evidence to support surgical
fusion for lumbar facetal joint pain other than that result-
ing from traumatic dislocation [1]. Gibson et al. in their
review on surgery for degenerative lumbar spondylosis re-
ported that eight trials on instrumented fusion produced
Figure 8 Sagittal T1-weighted contrast-enhanced subtraction
MR image. The image shows NPV in the left facet joints of the
treated pig that were treated with 300 J (marked by yellow circles).
Table 2 Summary of the average temperature rise and
its range






Summary of the average temperature measured at the focal point on the
targeted facet joint and the temperature measured in the nontargeted
intervertebral foramina located in the far field of the sonication according to the
acoustic energy delivered. Temperature measurements displayed in this table
were acquired using thermocouples. aIn one sonication (with an energy of 300 J),
the transducer orientation was such that the foramen was at the center of the
acoustic beam in the far field. In this case, temperature rise reached 5.2°C.
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outcomes and higher complication rates. Moreover, it
was difficult to assess fusion in the presence of metal
work in these trials [11].
A noninvasive, real-time, controlled, safe approach to
the treatment of facet joint pain is warranted, for which
MRgFUS provides a viable alternative. Utilizing the FUS
technique enables tailoring of precise ablation to cover
the entire facet joint surface in a single short session,
thereby limiting the ablation to the desired location and
enhancing the safety profile of the procedure. Furthermore,Figure 9 Facet joint demo model for human treatment. Axial T2-weigh
image on the right. The blue dashed line demonstrates a narrower beam p
of the transducer orientation since it minimizes the beam pass zone intersemultiple facet joints can be treated in a single session. The
MR guidance provides accurate anatomical visualization
for targeting of the facet joint, real-time monitoring, and
control of treatment using closed-loop thermal feedback
and immediate posttreatment evaluation of outcome using
contrast-enhanced imaging.
To enhance the safety of our method, we chose not to
target the proximal region of the median nerve but rather
to cover the entire facet surface where nerve endings ter-
minate to innervate the joint. By using this approach, we
maintained the ablation focus dorsal to the median branch
and therefore increased the safety profile of the procedure.
Treating the facet joints with energies of 150, 300, and
450 J resulted in a controlled heating at the facet joint
edge with no significant penetration to the vertebral body,
the spinal canal, or the root foramina. Based on the results
and accumulated data from bone metastases ablation [4-6],
we estimate that sonications of 150–450 J would provide
the desired therapeutic effect with a high safety profile. To
ascertain the safety margin, extreme-case scenarios were
tested, in some cases using energies of up to 1,200 J, with
lower frequencies than would be used during a clinical
procedure, (1 MHz instead of 1.35 MHz) with smaller and
less calcified vertebrae and in a media with no perfusionted planning image on the left and sagittal T2-weighted planning
ass when using apodization technique. This allows better optimization
ction with the vertebral spinous process.
Figure 10 Average of the temperature rise in the far field of the acoustic beam near the nerve roots. As measured using a thermocouple.
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above, the outcome was still well within the desired
safety parameters. Based on the animal studies and hu-
man simulation, our results indicate that treating while
using apodization is recommended since a narrower beam
allows for better optimization of the transducer orientation
against the sensitive locations in the beam pass zone. Even
in extreme-case scenarios that were tested with extreme
energies of up to 1,200 J and the worst orientation, our
results showed a maximal temperature rise of 6°C at the
spinal nerve roots, which is considered safe (see Table 1).
This diminutive increase in temperature following ultrasonic
ablation would likely not cause any permanent nerveFigure 11 Posttreatment images of the treated facet joints and treatm
T1-weighted contrast-enhanced MR image (left) showing small nonenhanc
tissue edema on the left facet joint that was treated with 150 J. This correl
overlay (predicated area of ablation). The lower strip shows multi-slice coro
NPV on the right facet joints that were treated with 450 J and soft tissue e
which correlate well with the blue dose overlay on multi-slice coronal PD Mtissue damage. As shown in other studies, nervous tissue
(such as the cranial nerve) present a threshold of 50°C to
60°C to cause permanent damage [12]. In addition, studies
done on peripheral nerves (sciatic nerve) showed that per-
manent damage and conduction block will happen only at
a temperature above 50°C [13].
The strength of the current study is that it combines
several in vitro and in vivo studies to test the safety and
efficacy of MRgFUS for facet joint ablation. Each experi-
ment compliments the other, thereby compensating for the
advantages and disadvantages of each.
The phantom experiment, with the combination of
thermal imaging, enables performing volumetric imaging,ent effect on facet joints treated with higher energies. Axial
ed area in the right facet joint that was treated with 450 J and soft
ates well with the axial PD MR image on the right with blue dose
nal T1-weighted contrast-enhanced subtraction MR images showing
dema adjacent to the left facet joints that were treated with 150 J,
R images in the upper strip.
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MRI. The thermocouple experiments generated a more
precise and absolute temperature reading but only in
limited locations and with decreased spatial certainty
due to the artifacts in MRI caused by the thermocouples.
The first experiment used thermocouples immersed in
water, simulating the nerve root immersed in cerebro-
spinal fluid. In the second experiment, thermocouples
were glued to the bone, again simulating an extreme-case
scenario where the nerve is touching the bone. The in vivo
pig experiment generates an online volumetric thermal
reading in an in vivo environment, with the same perfusion
and type of tissue as in a human subject. However, it
involves technical and financial difficulties and has the
shortcoming of different vertebral shapes and calcifications
(since pigs were young and vertebrae were smaller and less
calcified). Nevertheless, this could be an additional safety
consideration since it is expected that far field heating in
humans would be even lower than anything recorded in
the pigs. Human vertebrae are expected to be larger and
more calcified and are therefore better at blocking energy.
Another safety consideration will be the challenge of
planning and targeting the HIFU in humans, where we
expect to observe degenerative changes or irregular bony
surfaces. This obstacle will be overcome with high-
resolution MRI and planning. The benefits of the pig
experiments include correlation of the thermal dose
with the postprocedural imaging results (T2-weighted
and contrast-enhanced MR imaging). It also allows
clinical outcome evaluation over the follow-up period
for pigs 2 and 3, based on the veterinary exam, as well as
gross pathology evaluation of targeted and nontargeted
sensitive tissue following the dissection of pigs 1 and 2.
The imaging simulation of the healthy human volunteer is
advantageous since it shows the human anatomy of the
spine. Nevertheless, this is still a healthy volunteer with no
back pain due to facet joint problems. As such, human
volunteers suffering from facet joint pain should be tested
in future clinical trials.
We believe that similar to RF, MRgFUS will be found
to be an effective treatment with the advantage of being
completely noninvasive and possibly with higher ac-
curacy that may impact clinical outcomes. MRgFUS
provides long-term relief using a single noninvasive
treatment, eliminating the risk of bleeding and infec-
tion, thereby shortening recovery time and reducing mor-
bidity. Since MRgFUS is a radiation-free therapy, there are
no long-term toxicity or accumulated dosage effects. As
such, repeated treatments can be performed in the same
patient as many times as required. MRgFUS has a high
safety and efficacy profile and is accurate with support-
ing data. Other advantages of MRgFUS include its abil-
ity to localize the target tissue and monitor accuracy,
thermal effects, and treatment outcome in real time,without trajectory constraints, thereby optimizing target
coverage.
MRgFUS is already an established treatment for other
clinical applications such as uterine fibroid therapy (under
FDA and CE approval and the approval of the Ministries of
Health in Israel, Japan, and Korea, as well as other regula-
tory bodies around the world), with an excellent record of
safety and efficacy [14-16]. MRgFUS is also under clinical
investigation as a treatment for tumors of the breast [17-20],
prostate [21], liver [22,23], and brain [24-27]. Given its ex-
emplary safety and efficacy profile, the future of MRgFUS
for the treatment of facet joint pain is a bright one. The
results of the current study indicate that MRgFUS offers a
potentially novel alternative treatment for facet joint pain
palliation. Given its noninvasiveness, accuracy, safety, effi-
cacy, and the ability to be performed on an outpatient basis,
it may offer a revolutionary solution to patients suffering
from facet joint pain. Although further preclinical and clin-
ical studies are required, the current results are promising
and provide a solid basis for further exploration.
Conclusion
In conclusion, our results cumulatively show that MRgFUS
can safely and effectively target and ablate the facet joint.
This is the first study to demonstrate the potential of
MRgFUS to treat facet joint pain and may represent a
breakthrough in the treatment of chronic lower back
pain due to lumbar zygapophysial joint arthropathy.
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